đź“Š Evidence-Based Reference
clariti 1 day somofilcon a soft hydrophilic daily disposable contact lens with uv blocker
Coopervision
Summary: The clariti 1 day somofilcon a is a daily disposable contact lens with UV blocker, designed for vision correction. Key evidence highlights its subjective performance across age groups.
FDA Clearance Information
Pathway
510K
Number
K181920 ↗
Decision Date
December 11, 2018
Product Code
LPL
Device Class
Class 2
Evidence
419 studies
The clariti 1 day somofilcon a contact lens was cleared by the FDA via the 510k pathway on December 11, 2018. Manufactured by Coopervision, it is classified as a Class 2 medical device.
What It Is
The clariti 1 day somofilcon a is a soft, hydrophilic daily disposable contact lens with a UV blocker. It is intended for vision correction in individuals requiring contact lenses.
Clinical Applications
Commonly used in scenarios requiring daily disposable lenses, the clariti 1 day somofilcon a is suitable for patients seeking convenience and UV protection in their contact lenses.
Evidence Summary
The available literature includes 9 studies, comprising various study types such as RCTs and prospective studies, conducted between 2022 and 2023.
Reported Outcomes
Published studies report that the clariti 1 day somofilcon a lenses are associated with satisfactory subjective performance in children, teenagers, and young adults. Studies also explore the impact of lens handling, comfort, and vision on overall satisfaction.
Safety Profile
Reported complications include general discomfort and handling issues, as noted in subjective performance studies. No severe adverse events were highlighted in the provided evidence.
Evidence Limitations
The evidence is limited by a lack of long-term studies and a focus on subjective outcomes. Further research is needed to explore objective performance metrics and long-term safety.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for clariti 1 day somofilcon a?
The clariti 1 day somofilcon a is indicated for vision correction in individuals requiring daily disposable contact lenses with UV protection.
What outcomes have been reported in clinical studies?
Studies report satisfactory subjective performance, with factors like lens handling, comfort, and vision impacting overall satisfaction.
What complications have been reported?
Reported complications include general discomfort and handling issues, with no severe adverse events noted in the evidence.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.